Vineti Stock

Cell & Gene Therapy Software

Sign up today and learn more about Vineti Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Vineti Stock

Vineti is a commercial cloud-based platform to expand patient access to life-saving cells and gene therapies. It is a software solution to drive and scale personalized therapeutic innovation. It solves the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Founded in 2016, Vineti is headquartered in San Francisco, California.


Funding History

February 2017$14.1M
April 2018$33.5M
January 2020$31K
January 2020$75.2M
July 2020$94K


Chief Executive Officer

Amy DuRoss

Chief Financial Officer

Brett Robertson

Chief Technology Officer

Phil Calvin


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: